Torrent Pharmaceuticals profit falls 21.9% on acquisition costs
Investing.com Gold reports: Torrent Pharmaceuticals profit falls 21.9% on acquisition costs. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Torrent Pharmaceuticals profit falls 21.9% on acquisition costs. Full body text was unavailable at ingest time, so this brief is based on headline context.